Kristina Permyakova

Ms. Kristina Permyakova

The Federal Government Budgetary Institution “National Research Center for Epidemiology and Microbiology named after Honorary Academician N.F. Gamaleya of the Ministry of Health of the Russian Federation”, Moscow, Moskva, Russia
orcid

Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
7 December 2022 in Problems of Virology
Verified
Journal Article
Open access
PDF file
OMOlga Masalova
Olga Masalova
ELEkaterina Lesnova
Ekaterina Lesnova
SASergey M Andreev
Sergey M Andreev
NSNadezhda N. Shershakova
Nadezhda N. Shershakova
VKV V Kozlov
V V Kozlov
AKAlla Kushch
Alla Kushch
Introduction. A vaccine against hepatitis C has not yet been developed. Recombinant proteins and plasmids encoding hepatitis C virus (HCV) proteins, the components of candidate vaccines, induce a weak immune response and require the use of adjuvants. The aim of the work was to study the adjuvant action of an aqueous solution of fullerene C60 during immunization of mice with HCV recombinant protein NS5B (rNS5B) that is an RNA-dependent RNA polymerase, or with NS5B-encoding pcNS5B plasmid. Materials and methods. An aqueous solution of dispersed fullerene (dnC60) was obtained by ultrafiltration. C57BL/6 mice were immunized with rNS5B subcutaneously, pcNS5B intramuscularly mixed with different doses of dnC60 three times, then the humoral and cellular response to HCV was evaluated. Results. Mice immunization with rNS5B in a mixture with dnC60 at doses of 250 g/mouse significantly induced humoral response: a dose-dependent increase in IgG1 antibody titers was 720 times higher than in the absence of fullerene. There was no increase in the cellular response to rNS5B when administered with dnC60. The humoral response to DNA immunization was weak in mice of all groups receiving pcNS5B. The cellular response was suppressed when the plasmid was injected in a mixture with dnC60. Conclusions. Dispersed fullerene dnC60 is a promising adjuvant for increasing the immunostimulating activity of weakly immunogenic proteins including surface and other HCV proteins, important for a protective response. Further research is needed to enhance the ability of dnC60 to boost the cellular immune response to the components of the candidate vaccine.

10 December 2023 in International Journal of Veterinary Medicine
Verified
Journal Article
Open access
PDF file
NPN. V. Pimenov
N. V. Pimenov
SLS. V. Laptev
S. V. Laptev
KPKristina Permyakova
Kristina Permyakova
SMSaida Marzanova
Saida Marzanova
RIR. F. Ivannikova
R. F. Ivannikova
КПК. Ю. Пермякова
К. Ю. Пермякова
Innate immunity plays a decisive role in the primary reaction of the body to microbial agents. It is realized through the activation of cellular and humoral factors of nonspecific resistance – neutrophils, macrophages and antimicrobial and regulatory substances secreted by them, which, in turn, trigger a cascade of reactions involving lymphocytes. On the surface of the mucous membranes and in mucosal secretions, neutrophils realize their function not only through phagocytosis, but also through the release of DNA and bactericidal granules that form neutrophil extracellular traps. Violation of the functioning of these cells on the surface of the mucous membranes is considered as one of the factors of the formation of pathological microbial communities, leading to the development of dysbiosis and inflammation of various localization. The completed character of phagocytosis is provided by microbicidal systems of leukocytes: cationic proteins and myeloperoxidase. They have a special immunological significance and influence the course and outcome of the disease. Myeloperoxidase and cationic proteins are the main factors of bactericidal protection.

21 September 2023 in Problems of Virology
Verified
Journal Article
Open access
PDF file
ELEkaterina Lesnova
Ekaterina Lesnova
OMOlga Masalova
Olga Masalova
KPKristina Permyakova
Kristina Permyakova
NDNatalia Andreevna Demidova
Natalia Andreevna Demidova
VVVladimir T. Valuev-Elliston
Vladimir T. Valuev-Elliston
AKAlla Kushch
Alla Kushch
Introduction. Hepatitis C is a liver disease with high chronicity, the cause of cirrhosis and hepatocarcinoma. The main obstacle to controlling hepatitis C is the lack of vaccines. The aim of the work was to compare the immunogenic activity of nonstructural recombinant proteins NS3, NS4 and NS5B of hepatitis C virus (HCV) as components of a subunit candidate vaccine and to analyze the adjuvant properties of two available commercial drugs, polymuramil and pyrogenalum. Materials and methods. BALB/c, DBA/2J and C57BL/6 mice were immunized with nonstructural proteins without adjuvants or with polymuramyl (NOD1 and NOD2 agonist) and pyrogenalum (TLR-4 agonist). The activity of antibodies was determined in ELISA, the cellular response by antigen-specific lymphocyte proliferation and by production of IFN- in vitro. Results. Recombinant proteins showed different immunogenicity. NS4 induced antibodies more efficiently than NS3 and NS5B. Significant differences were found in the immune response of three inbred lines mice: the level of IFN- in BALB/c and DBA/2J mice induced by NS5B protein was 30 times higher than in C57Bl/6 mice. In contrast, the induction of antibodies in BALB/c mice was lower than in C57Bl/6 and DBA/2J. Polymuramil did not increase the humoral response to NS5B and enhanced the cellular response only in C57BL/6 mice. The combined use of polymuramil with pyrogenalum significantly increased both the humoral and cellular response of mice to all recombinant HCV proteins. Conclusion. Different immunogenic properties and different functions of recombinant non-structural HCV proteins indicate the feasibility of their combined inclusion in subunit vaccines. It was established for the first time that immunization with HCV proteins with a complex adjuvant (polymuramyl + pyrogenalum) has a synergistic effect, significantly exceeding the effect of each of them separately.

Verified
Journal Article
Open access
PDF file
ELEkaterina Lesnova
Ekaterina Lesnova
OMOlga Masalova
Olga Masalova
KPKristina Permyakova
Kristina Permyakova
VKVyacheslav V. Kozlov
Vyacheslav V. Kozlov
TNTatyana N. Nikolaeva
Tatyana N. Nikolaeva
AKAlla Kushch
Alla Kushch
Hepatitis C virus (HCV) is one of the main triggers of chronic liver disease. Despite tremendous progress in the HCV field, there is still no vaccine against this virus. Potential vaccines can be based on its recombinant proteins. To increase the humoral and, especially, cellular immune response to them, more effective adjuvants are needed. Here, we evaluated a panel of compounds as potential adjuvants using the HCV NS5B protein as an immunogen. These compounds included inhibitors of polyamine biosynthesis and urea cycle, the mTOR pathway, antioxidants, and cellular receptors. A pronounced stimulation of cell proliferation and interferon-γ (IFN-γ) secretion in response to concanavalin A was shown for antioxidant N-acetylcysteine (NAC), polyamine biosynthesis inhibitor 2-difluoromethylornithine (DFMO), and TLR9 agonist CpG ODN 1826 (CpG). Their usage during the immunization of mice with the recombinant NS5B protein significantly increased antibody titers, enhanced lymphocyte proliferation and IFN-γ production. NAC and CpG decreased relative Treg numbers; CpG increased the number of myeloid-derived suppressor cells (MDSCs), whereas neither NAC nor DFMO affected MDSC counts. NAC and DFMO suppressed NO and interleukin 10 (IL-10) production by splenocytes, while DFMO increased the levels of IL-12. This is the first evidence of immunomodulatory activity of NAC and DFMO during prophylactic immunization against infectious diseases.

13 October 2022 in International Journal of Veterinary Medicine
Verified
Journal Article
Open access
PDF file
NPN. V. Pimenov
N. V. Pimenov
SLS. V. Laptev
S. V. Laptev
KPKristina Permyakova
Kristina Permyakova
RIR. F. Ivannikova
R. F. Ivannikova
SMSaida Marzanova
Saida Marzanova
КПК. Ю. Пермякова
К. Ю. Пермякова
КРИТЕРИИ В ПРОГНОСТИКЕ ГЕНЕРАЛИЗАЦИИ БАКТЕРИОЗОВ У СОБАК С ВОСПАЛЕНИЕМ МАТКИ

9 October 2023 in International Journal of Veterinary Medicine
Verified
Journal Article
Open access
PDF file
SLS. V. Laptev
S. V. Laptev
NPN. V. Pimenov
N. V. Pimenov
SMSaida Marzanova
Saida Marzanova
KPKristina Permyakova
Kristina Permyakova
RIR. F. Ivannikova
R. F. Ivannikova
КПК. Ю. Пермякова
К. Ю. Пермякова
This study examines approaches to assessing the risk of death and predicting the development of sepsis in dogs. Sepsis remains one of the key clinical problems in medicine and veterinary medicine, due to its widespread prevalence throughout the world, leading to high mortality. Sepsis is based on the reaction of systemic inflammation of the body, which is realized in the presence of signs of SIRS, bacteremia and/or an infectious focus of various nature in combination with acute signs of organ dysfunction and/or evidence of microbial dissemination. Since sepsis develops only progressively, it is impossible for the animal to recover independently without providing it with timely and appropriate medical care. Today, one of the key issues remains improving approaches to assessing the risk of death and predicting the development of sepsis in dogs. An attempt to combine the pathogenicity factors of an infectious agent and the failure of the host’s defense mechanisms is reflected in the concepts of PIRO, SAPS and MODS, which evaluate the links in the etiopathogenesis of sepsis. Thus, heuristic approaches will allow us to come closer to the development of pathogenetically based methods for assessing the risk of death of animals and predicting the development of sepsis in dogs. These approaches are based on criteria for assessing PIRO indicators: predisposition (P), including breed, sex, age of the animal; infection (I) associated with the type of pathogen detected; systemic response of the body to infection R, characterized by the main clinical indicators - body temperature, heart rate, respiratory rate and the number of leukocytes in the blood; organ dysfunction (O) identified in one or more organs of the animal. An important role in the objective prognosis is given to the evaluation criteria on the SAPS scale, taking into account changes in indicators towards hyperinflammation (SIRS) or immunosuppression (MODS), which determine the stage of development of sepsis and the likelihood of the risk of death of the sick animal. On average, the predictive accuracy of quantifying disease severity systems is 70–85%. An algorithm for translating clinical and laboratory data into a SAPS scale of indicators (scores) that determines the severity of the disease in leptospirosis in dogs is proposed. It has been shown that on the SAPS scale for canine leptospirosis, a score of 29